Ledger.Open graph →
SEC Form D · filed January 24, 2018

Dracen Pharmaceuticals, Inc

Offering
$40.5M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Thomas M. Estok · Baltimore, MDExec · DirectorJonathan M. Leff · New York, NYDirectorDrew M. Pardoll, M.D., Ph.D · Baltimore, MDDirectorAsher M. Rubin · Baltimore, MDExecRobert M. Jackson · New York, NYDirectorDrew M. Pardoll, M.D., Ph.D · Baltimore, MDDirectorThomas M. Estok · San Diego, CAExec · DirectorJonathan M. Leff · New York, NYDirectorAsher M. Rubin · Baltimore, MDExecRobert M. Jackson · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗